Objectives: Explore the feasibility and safety of using foldable capsular vitreous body (FCVB) in managing severe ocular trauma and silicone oil-dependent eyes. Methodology: This is a retrospective study that analyzed 61 ocular trauma patients (61 eyes) that were presented to the Department of Eye Emergency, Hebei Eye Hospital from May 1, 2018, to May 31, 2019, which included 51 male patients (51 eyes) and 10 female patients (10 eyes) with an average age of (44.98 ±14.60) years old. The oldest patient was 75 years old and the youngest was 8 years old. These cases represented 51 eyes with severe eyeball rupture and 10 eyes with severe, complicated ocular trauma, which became silicone oil-dependent after the operation. These patients received FCVB implants and their visual acuity, intraocular pressure, and the changes on their eye axis, cornea, retina, and the state of FCVB were recorded after the operation. Results: The operations were successful for all patients and the implants were in the correct positions upon the completion of the operation. All 61 patients cleared a follow-up window of 1-6 months with no reports of significant changes in their visual acuity. Among the patients, 91.8% reported normal intraocular pressure, the retinal reattachment rate reached 100%, and the eyeball atrophy control rate reached 100%. There was no report of rupture of the FCVB allergies to silicone, intraocular infection, intraocular hemorrhage, silicone oil emulsification, or sympathetic ophthalmia. Conclusions: Foldable capsular vitreous bodies (FCVBs) designed to mimic natural vitreous bodies are suitable as long-term ocular implants that can provide sustained support for the retina without the need for any special postoperative postures. Their barrier function may effectively prolong the retention time of the filling medium and prevent various complications caused by direct contact of the eye tissues with the filling medium.